Assignee
CETUS ONCOLOGY CORP
US·26 granted patents·2,389 citations·filing 1988–1995
Top patents by PatentIndex Score
26 records- 0198US5281698APreparation of an activated polymer ester for protein conjugationCETUS ONCOLOGY CORP·Filed 1991·Granted Jan 25, 1994·621 cites·20 claims
- 0297US5169774AMonoclonal anti-human breast cancer antibodiesCETUS ONCOLOGY CORP·Filed 1988·Granted Dec 8, 1992·148 cites·4 claims
- 0396US5206344AInterleukin-2 muteins and polymer conjugation thereofCETUS ONCOLOGY CORP·Filed 1988·Granted Apr 27, 1993·948 cites·12 claims
- 0492US5397703AMethod for generation of antibodies to cell surface moleculesCETUS ONCOLOGY CORP·Filed 1992·Granted Mar 14, 1995·57 cites·17 claims
- 0588US5591827AInterleukin-6 receptor antagonistsCETUS ONCOLOGY CORP·Filed 1994·Granted Jan 7, 1997·82 cites·20 claims
- 0684US5324655AHuman Y-interferon signal peptide-tumor necrosis factor(TNF) gene fusionsCETUS ONCOLOGY CORP·Filed 1992·Granted Jun 28, 1994·51 cites·4 claims
- 0782US5503841AHuman IL-2 as a vaccine adjuvantCETUS ONCOLOGY CORP·Filed 1989·Granted Apr 2, 1996·66 cites·16 claims
- 0879US5234839ACompositions for detecting ras gene proteins and cancer therapeuticsCETUS ONCOLOGY CORP·Filed 1991·Granted Aug 10, 1993·47 cites·8 claims
- 0978USRE35171ECompositions for detecting ras gene proteins and cancer therapeuticsCETUS ONCOLOGY CORP·Filed 1994·Granted Mar 5, 1996·36 cites·18 claims
- 1076US5573930ADNA encoding various forms of colony stimulating factor-1CETUS ONCOLOGY CORP·Filed 1992·Granted Nov 12, 1996·31 cites·17 claims
- 1175US6238891B1Method of increasing product expression through solute stressCETUS ONCOLOGY CORP·Filed 1995·Granted May 29, 2001·31 cites·21 claims
- 1275US5425940ACombination therapy using interleukin-2 and tumor necrosis factorCETUS ONCOLOGY CORP·Filed 1994·Granted Jun 20, 1995·50 cites·24 claims
- 1373US5508031AMethod for treating biological damage using a free-radial scavenger and interleukin-2CETUS ONCOLOGY CORP·Filed 1994·Granted Apr 16, 1996·36 cites·17 claims
- 1472US5491065AMonoclonal antibodies that bind to and neutralize dimeric but not monomeric human M-CSF and methods of use thereof for detection of dimeric M-CSFCETUS ONCOLOGY CORP·Filed 1993·Granted Feb 13, 1996·36 cites·10 claims
- 1570US5455330AInterleukin-1 antagonist and uses thereofCETUS ONCOLOGY CORP·Filed 1993·Granted Oct 3, 1995·31 cites·1 claims
- 1670US5422425AMethods for the identification of cytokine convertase inhibitorsCETUS ONCOLOGY CORP·Filed 1993·Granted Jun 6, 1995·21 cites·2 claims
- 1765US5276140ACross-linking agentsCETUS ONCOLOGY CORP·Filed 1991·Granted Jan 4, 1994·8 cites·4 claims
- 1860US5556620AUse of recombinant colony stimulating factor-1 to enhance wound healingCETUS ONCOLOGY CORP·Filed 1994·Granted Sep 17, 1996·14 cites·8 claims
- 1960US5538868ARecombinant ricin toxin fragmentsCETUS ONCOLOGY CORP·Filed 1995·Granted Jul 23, 1996·12 cites·10 claims
- 2060US5470569ARecombinant colony stimulating factor-1CETUS ONCOLOGY CORP·Filed 1994·Granted Nov 28, 1995·14 cites·8 claims
- 2155US5248769AProcess for recovering refractile bodies containing heterologous proteins from microbial hostsCETUS ONCOLOGY CORP·Filed 1991·Granted Sep 28, 1993·13 cites·20 claims
- 2252US5545518AAssay for determinig TNF or IL-1 convertase activityCETUS ONCOLOGY CORP·Filed 1995·Granted Aug 13, 1996·10 cites·12 claims
- 2352US5464936ACompositions for identification of papillomavirus replication inhibitorsCETUS ONCOLOGY CORP·Filed 1990·Granted Nov 7, 1995·9 cites·4 claims
- 2451US5276180AProcess for making succinyl acetoneCETUS ONCOLOGY CORP·Filed 1989·Granted Jan 4, 1994·3 cites·11 claims
- 2546US5422105AUse of recombinant colony stimulating factor 1CETUS ONCOLOGY CORP·Filed 1994·Granted Jun 6, 1995·11 cites·19 claims
- 2639US5164305AStreptomyces promoter and method of use thereofCETUS ONCOLOGY CORP·Filed 1990·Granted Nov 17, 1992·3 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when CETUS ONCOLOGY CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →